Netherlands (Kingdom of the) vs Norway: Percentage of bloodstream infection due to methicillin-resistant
Netherlands (Kingdom of the)
2.3%
in 2022
Norway
0.9%
in 2021
Netherlands (Kingdom of the) rank
47th
Norway rank
50th
Percentage of bloodstream infection due to methicillin-resistant over time
- Netherlands (Kingdom of the)
- Norway
How they compare
Netherlands (Kingdom of the) currently reports 2.3% against 0.9% in Norway, a difference of 1.4%.
That makes Netherlands (Kingdom of the)'s figure about 2.5 times Norway's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Netherlands (Kingdom of the) ahead.
Netherlands (Kingdom of the) ranks 47th and Norway ranks 50th of 50 countries.
Netherlands (Kingdom of the) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands (Kingdom of the) | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.1% | 0.4% | Netherlands (Kingdom of the) |
| 2020s | 1.6% | 1.5% | 0.1% | Netherlands (Kingdom of the) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Netherlands (Kingdom of the) or Norway?
- Netherlands (Kingdom of the), at 2.3% against 0.9% in Norway as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Netherlands (Kingdom of the) and Norway?
- 1.4%, with Netherlands (Kingdom of the) ahead.
- How many years of comparable data are there for Netherlands (Kingdom of the) and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Netherlands (Kingdom of the) and Norway rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Netherlands (Kingdom of the) ranks 47th and Norway ranks 50th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.